RxDoctor Payments Data

Georges Al-Khoury

Vascular Surgery · Pittsburgh, PANPI 1134453616

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $2,548 of the $3,845 with a category attached, or 66.3%. W. L. Gore & Associates, Inc. accounts for 72.3% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $3,334 and has fallen 87.7% since, to $409 in 2025. That places this record below the midpoint for vascular surgery clinicians in PA, where the typical reported total is $3,795.

$3,845in general payments, 2019–2025

Across 28 payments — averaging $137.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • W. L. Gore & Associates, Inc.$3K
  • Silk Road Medical, Inc.$800
  • Endologix LLC$142
  • Cook Medical LLC$69
  • Cardiva Medical, Inc.$25
  • Globus Medical$17
  • plus $13 from 1 others
$51,641in research payments, 2019–2025

Across 21 payments — averaging $2459.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • W. L. Gore & Associates, Inc.$49K
  • Philips North America LLC$3K

What the payments were for

  • Travel & lodging$2,54866%
  • Food & beverage$1,29834%

General payments by program year

19
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,845 in reported general payments places this provider in the 50th percentile of 236 vascular surgery providers in Pennsylvania.

See all vascular surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$119,807
Medicare patients
555
Services billed
910

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban44$45,644
ClopidogrelClopidogrel Bisulfate228$2,514
Gabapentin17$74
Prednisone24$19

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →